A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas

A April A. Apfelbaum E Eric Morin D Dominik Sturm G Georges Ayoub J Jeromy DiGiacomo S Sher Bahadur B Bhavyaa Chandarana P Phoebe C. Power M Margaret M. Cusick D Dana Novikov P Prem Prabhakar R Robert E. Jones J Jayne Vogelzang C Connor C. Bossi S Seth Malinowski L Lewis M. Woodward T Tania A. Jones J John Jeang S Sarah W. Lamson J Jared Collins K Kelly Y. Cai J Jacquelyn S. Jones S Sehee Oh H Hyesung Jeon J Jinhua Wang A Amy Cameron P Patrick Rechter A Angela De Leon K Karthikeyan Murugesan M Meagan Montesion L Lee A. Albacker S Shakti H. Ramkissoon C Cornelis M. van Tilburg E Emily C. Hardin P Philipp Sievers F Felix Sahm K Kee Kiat Yeo T Tom Rosenberg S Susan N. Chi K Karen D. Wright S Steven Hébert S Sydney Peck A Alberto Picca V Valérie Larouche S Samuele Renzi S Sara J. Buhrlage (Department of Cancer Biology, Dana-Farber Cancer Institute) T Tejus A. Bale A Amy A. Smith M Mehdi Touat N Nada Jabado E Eric S. Fischer M Michael J. Eck L Lissa Baird O Olaf Witt C Claudia L. Kleinman Q Quang-De Nguyen D Denise Sheer S Sanda Alexandrescu D David T. W. Jones K Keith L. Ligon P Pratiti Bandopadhayay